Hopes rise again for Alzheimer's drug after study by Biogen and Japan's Eisai
The two companies have developed a drug that slows cognitive decline 30 percent and eliminates brain plaque, but they’re also using a new gauge to measure that.
Pill-popping is a business worth watching for Japan's drugmakers
To eke out growth in one of the developed world's most sluggish pharmaceutical markets, Japanese drugmakers are turning to the pill-popping behavior of their customers. Medication adherence is seen as an impediment to health as well as sales in Japan, and companies including Otsuka Pharmaceutical ...
Just days after Biogen Inc. revealed promising early data from an experimental Alzheimer's treatment, new research from the Mayo Clinic may revive a long-running debate over whether the drug industry is focusing on the right target in developing therapies to treat the disease. The study, ...
